Treatment of small and medium congenital nevi with the Q-switched ruby laser.

Treatment of small and medium congenital nevi with the Q-switched ruby laser. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Treatment of small and medium congenital nevi with the Q-switched ruby laser. Abstract Text:

BACKGROUND: The Q-switched ruby laser has been used successfully to treat a variety of benign pigmented lesions. In this study, congenital nevi (diameter, < or = 5 cm) in 18 prepubertal children were treated with the Q-switched ruby laser. OBSERVATIONS: Photographic evaluation revealed an average of 57% clearance of pigmentation in all treated nevi by the fourth treatment session and an average maximum clearance of 76% after approximately eight sessions. Greater than 90% clearance of pigment was attained in five patients. Partial repigmentation was seen in all patients who were followed up after discontinuation of therapy. Findings from histopathologic studies, obtained from one patient, revealed reduction of nevus cells in papillary dermis and upper reticular dermis that correlated with clinical lightening. There was no such reduction in the lower reticular dermis. side effects were limited to transient erythema and hypopigmentation. CONCLUSIONS: The Q-switched ruby laser effectively lightens and may clear pigmentation and eliminate superficial nevus cells from small and medium congenital nevi safely without scarring. However, these results are not permanent. The Q-switched ruby laser may be a viable alternative for providing cosmetic improvement for unresectable lesions, but it should not be considered definitive treatment. Additional studies are needed to address the long-term results of this therapy.

Treatment of small and medium congenital nevi with the Q-switched ruby laser. Publishing Authors By Initials

For similar neoplasms: neoplasms by site: skin neoplasms research abstracts see: neoplasms: neoplasms by site: skin neoplasms research

PUBMED ID PMID:

MEDLINE DATE:

Treatment of small and medium congenital nevi with the Q-switched ruby laser. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Archives of dermatology

VOLUME: 132

Page Numbers: 301-4

Journal Abbreviation: Arch Dermatol

ISSN: 0003-987X

DAY: 17

MONTH: Mar

YEAR: 1996

Treatment of small and medium congenital nevi with the Q-switched ruby laser. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 372433

Treatment of small and medium congenital nevi with the Q-switched ruby laser. Keywords Mesh Terms:

KEYWORDS: Skin Neoplasms

MESH TERMS: radiotherapy

Chemical & Substance for Abstract: Treatment of small and medium congenital nevi with the Q-switched ruby laser. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Treatment of small and medium congenital nevi with the Q-switched ruby laser.

AFFILIATION: Laser and Skin Surgery Center, New York, USA.

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Arch Dermatol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Treatment of small and medium congenital nevi with the Q-switched ruby laser Related Publications

• Anatomical differences of port-wine stains in response to treatment with the pulsed dye laser.
• Arteriovenous malformation treated with embolization and laser therapy.
• Basal cell carcinoma arising 57 years after interstitial radiotherapy of a nasal hemangioma.
• Capillary hemangiomas and treatment with the flash lamp-pumped pulsed dye laser.
• Deep venous thrombosis following Mohs micrographic surgery: case report.
• Detection of human papillomavirus DNA in squamous cell carcinoma of the nail bed and finger determined by polymerase chain reaction.
• Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases.
• Lack of efficacy of the Q-switched ruby laser in the treatment of vitiligo.
• Laser-mediated photodynamic therapy of actinic keratoses.
• Poikiloderma of civatte.
• Successful treatment of acneiform scarring with CO2 ablative fractional resurfacing.
• The safety and efficacy of the 308-nm excimer laser for pigment correction of hypopigmented scars and striae alba.
• Thrombocytopenia-absent radii syndrome and lack of response to the pulsed dye laser.
• Treatment of nasolabial folds and jowls with a noninvasive radiofrequency device.
• Treatment of small and medium congenital nevi with the Q-switched ruby laser.
• Ultraviolet-laser ablation of skin.
• Use of the 308-nm excimer laser for postresurfacing leukoderma.